Chemours (CC)
13.72
-0.57 (-3.99%)
At close: Mar 28, 2025, 3:59 PM
13.80
0.56%
After-hours: Mar 28, 2025, 06:21 PM EDT
Chemours Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | 5.78B | 6.03B | 6.79B | 6.34B | 4.97B | 5.53B | 6.64B | 6.18B | 5.4B | 5.72B | 6.43B | 6.86B | 7.37B | 7.97B |
| Cost of Revenue | 4.63B | 4.72B | 5.18B | 4.96B | 3.9B | 4.46B | 4.67B | 4.43B | 4.29B | 4.76B | 5.07B | 5.39B | 5.01B | 5.38B |
| Gross Profit | 1.15B | 1.31B | 1.62B | 1.38B | 1.07B | 1.06B | 1.97B | 1.75B | 1.11B | 955M | 1.36B | 1.46B | 2.35B | 2.6B |
| Operating Income | 457M | -92M | 913M | 888M | 509M | 171M | 1.23B | 1.07B | 96M | 226M | 532M | 532M | 1.46B | 1.73B |
| Interest Income | n/a | n/a | 163M | 185M | 210M | 208M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | 127M | -318M | 741M | 676M | 179M | -124M | 1.16B | 912M | -11M | -188M | 550M | 576M | 1.49B | 1.91B |
| Net Income | 86M | -238M | 578M | 608M | 219M | -52M | 995M | 746M | 7M | -90M | 400M | 423M | 1.06B | 1.43B |
| Selling & General & Admin | 585M | 1.29B | 710M | 592M | 527M | 548M | 657M | 602M | 934M | 632M | 685M | 768M | 747M | 731M |
| Research & Development | 109M | 108M | 118M | 107M | 93M | 80M | 82M | 80M | 80M | 97M | 143M | 164M | 145M | 135M |
| Other Expenses | n/a | n/a | 70M | 163M | 39M | -293M | 162M | 79M | 247M | 44M | 45M | 48M | 42M | 55M |
| Operating Expenses | 694M | 1.4B | 828M | 699M | 620M | 628M | 739M | 682M | 1.01B | 729M | 828M | 932M | 892M | 866M |
| Interest Expense | 264M | 208M | 163M | 185M | 210M | 208M | 195M | 215M | 213M | 132M | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 5.33B | 6.11B | 6.01B | 5.66B | 4.52B | 5.09B | 5.41B | 5.11B | 5.3B | 5.49B | 5.9B | 6.33B | 5.91B | 6.24B |
| Income Tax | 41M | -81M | 163M | 68M | -40M | -72M | 159M | 165M | -18M | -98M | 149M | 152M | 427M | 474M |
| Shares Outstanding (Basic) | 149.49M | 148.91M | 155.36M | 164.94M | 164.68M | 164.82M | 176.97M | 184.84M | 181.62M | 180M | 181.37M | 181.37M | 181.37M | 181.37M |
| Shares Outstanding (Diluted) | 150.01M | 148.91M | 158.3M | 168.7M | 166.35M | 164.82M | 182.57M | 190.98M | 183.42M | 180.99M | 182.76M | 182.76M | 182.76M | 182.76M |
| EPS (Basic) | 0.58 | -1.6 | 3.72 | 3.69 | 1.33 | -0.32 | 5.62 | 4.04 | 0.04 | -0.5 | 2.21 | 2.33 | 5.83 | 7.89 |
| EPS (Diluted) | 0.57 | -1.6 | 3.65 | 3.60 | 1.32 | -0.32 | 5.45 | 3.91 | 0.04 | -0.5 | 2.19 | 2.31 | 5.78 | 7.83 |
| EBITDA | 692M | 197M | 1.2B | 1.21B | 767M | 482M | 1.54B | 1.34B | 715M | 211M | 789M | 793M | 1.73B | 2B |
| Depreciation & Amortization | 301M | 307M | 291M | 317M | 320M | 311M | 284M | 273M | 284M | 267M | 257M | 261M | 266M | 272M |